MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis
Background/Aims: Treatment options for metastatic castrate-resistant prostate cancer (mCRPC) are limited and typically centered on paclitaxel-based chemotherapy. In this study, we aimed to evaluate whether miR-34a attenuates chemoresistance to paclitaxel by regulating target genes associated with dr...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-10-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/494004 |
id |
doaj-7e2d68be2fb44755b2f329266a5d8bb1 |
---|---|
record_format |
Article |
spelling |
doaj-7e2d68be2fb44755b2f329266a5d8bb12020-11-24T21:22:23ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-10-0150126127610.1159/000494004494004MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 AxisXiaobing LiuXing LuoYuqi WuDing XiaWei ChenZhenqiang FangJianping DengYaxing HaoXia YangTeng ZhangLuqiang ZhouYingbing WuQingqing WangJie XuXiaoyan HuLongkun LiBackground/Aims: Treatment options for metastatic castrate-resistant prostate cancer (mCRPC) are limited and typically centered on paclitaxel-based chemotherapy. In this study, we aimed to evaluate whether miR-34a attenuates chemoresistance to paclitaxel by regulating target genes associated with drug resistance. Methods: We used data from The Cancer Genome Atlas to compare miR-34a expression levels in prostate cancer (PC) tissues with normal prostate tissues. The effects of miR-34a inhibition and overexpression on PC proliferation were evaluated in vitro via Cell Counting Kit-8 (CCK-8) proliferation, colony formation, apoptosis, and cell-cycle assays. A luciferase reporter assay was employed to identify the interactions between miR-34a and specific target genes. To determine the effects of up-regulation of miR-34a on tumor growth and chemo-resistance in vivo, we injected PC cells overexpressing miR-34a into nude mice subcutaneously and evaluated the rate of tumor growth during paclitaxel treatment. We examined changes in the expression levels of miR-34a target genes JAG1 and Notch1 and their downstream genes via miR-34a transfection by quantitative reverse transcription PCR (qRT-PCR) and western blot assay. Results: miR-34a served as an independent predictor of reduced patient survival. MiR-34a was down-regulated in PC-3PR cells compared with PC-3 cells. The CCK-8 assay showed that miR-34a overexpression resulted in increased sensitivity to paclitaxel while miR-34a down-regulation resulted in chemoresistance to paclitaxel in vitro. A study of gain and loss in a series of functional assays revealed that PC cells expressing miR-34a were chemosensitive. Furthermore, the overexpression of miR-34a increased the sensitivity of PC-3PR cells to chemotherapy in vivo. The luciferase reporter assay confirmed that JAG1 and Notch1 were directly targeted by miR-34a. Interestingly, western blot analysis and qRT-PCR confirmed that miR-34a inhibited the Notch1 signaling pathway. We found that miR-34a increased the chemosensitivity of PC-3PR cells by directly repressing the TCF1/ LEF1 axis. Conclusion: Our results showed that miR-34a is involved in the development of chemosensitivity to paclitaxel. By regulating the JAG1/Notch1 axis, miR-34a or its target genes JAG1 or Notch1 might serve as potential predictive biomarkers of response to paclitaxel-based chemotherapy and/or therapeutic targets that will help to overcome chemoresistance at the mCRPC stage.https://www.karger.com/Article/FullText/494004miR-34a sChemoresistancePaclitaxelProstate cancerJAG1Notch1 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiaobing Liu Xing Luo Yuqi Wu Ding Xia Wei Chen Zhenqiang Fang Jianping Deng Yaxing Hao Xia Yang Teng Zhang Luqiang Zhou Yingbing Wu Qingqing Wang Jie Xu Xiaoyan Hu Longkun Li |
spellingShingle |
Xiaobing Liu Xing Luo Yuqi Wu Ding Xia Wei Chen Zhenqiang Fang Jianping Deng Yaxing Hao Xia Yang Teng Zhang Luqiang Zhou Yingbing Wu Qingqing Wang Jie Xu Xiaoyan Hu Longkun Li MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis Cellular Physiology and Biochemistry miR-34a s Chemoresistance Paclitaxel Prostate cancer JAG1 Notch1 |
author_facet |
Xiaobing Liu Xing Luo Yuqi Wu Ding Xia Wei Chen Zhenqiang Fang Jianping Deng Yaxing Hao Xia Yang Teng Zhang Luqiang Zhou Yingbing Wu Qingqing Wang Jie Xu Xiaoyan Hu Longkun Li |
author_sort |
Xiaobing Liu |
title |
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis |
title_short |
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis |
title_full |
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis |
title_fullStr |
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis |
title_full_unstemmed |
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis |
title_sort |
microrna-34a attenuates paclitaxel resistance in prostate cancer cells via direct suppression of jag1/notch1 axis |
publisher |
Cell Physiol Biochem Press GmbH & Co KG |
series |
Cellular Physiology and Biochemistry |
issn |
1015-8987 1421-9778 |
publishDate |
2018-10-01 |
description |
Background/Aims: Treatment options for metastatic castrate-resistant prostate cancer (mCRPC) are limited and typically centered on paclitaxel-based chemotherapy. In this study, we aimed to evaluate whether miR-34a attenuates chemoresistance to paclitaxel by regulating target genes associated with drug resistance. Methods: We used data from The Cancer Genome Atlas to compare miR-34a expression levels in prostate cancer (PC) tissues with normal prostate tissues. The effects of miR-34a inhibition and overexpression on PC proliferation were evaluated in vitro via Cell Counting Kit-8 (CCK-8) proliferation, colony formation, apoptosis, and cell-cycle assays. A luciferase reporter assay was employed to identify the interactions between miR-34a and specific target genes. To determine the effects of up-regulation of miR-34a on tumor growth and chemo-resistance in vivo, we injected PC cells overexpressing miR-34a into nude mice subcutaneously and evaluated the rate of tumor growth during paclitaxel treatment. We examined changes in the expression levels of miR-34a target genes JAG1 and Notch1 and their downstream genes via miR-34a transfection by quantitative reverse transcription PCR (qRT-PCR) and western blot assay. Results: miR-34a served as an independent predictor of reduced patient survival. MiR-34a was down-regulated in PC-3PR cells compared with PC-3 cells. The CCK-8 assay showed that miR-34a overexpression resulted in increased sensitivity to paclitaxel while miR-34a down-regulation resulted in chemoresistance to paclitaxel in vitro. A study of gain and loss in a series of functional assays revealed that PC cells expressing miR-34a were chemosensitive. Furthermore, the overexpression of miR-34a increased the sensitivity of PC-3PR cells to chemotherapy in vivo. The luciferase reporter assay confirmed that JAG1 and Notch1 were directly targeted by miR-34a. Interestingly, western blot analysis and qRT-PCR confirmed that miR-34a inhibited the Notch1 signaling pathway. We found that miR-34a increased the chemosensitivity of PC-3PR cells by directly repressing the TCF1/ LEF1 axis. Conclusion: Our results showed that miR-34a is involved in the development of chemosensitivity to paclitaxel. By regulating the JAG1/Notch1 axis, miR-34a or its target genes JAG1 or Notch1 might serve as potential predictive biomarkers of response to paclitaxel-based chemotherapy and/or therapeutic targets that will help to overcome chemoresistance at the mCRPC stage. |
topic |
miR-34a s Chemoresistance Paclitaxel Prostate cancer JAG1 Notch1 |
url |
https://www.karger.com/Article/FullText/494004 |
work_keys_str_mv |
AT xiaobingliu microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT xingluo microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT yuqiwu microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT dingxia microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT weichen microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT zhenqiangfang microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT jianpingdeng microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT yaxinghao microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT xiayang microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT tengzhang microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT luqiangzhou microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT yingbingwu microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT qingqingwang microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT jiexu microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT xiaoyanhu microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis AT longkunli microrna34aattenuatespaclitaxelresistanceinprostatecancercellsviadirectsuppressionofjag1notch1axis |
_version_ |
1725996094216732672 |